The stock fell despite the company significantly increasing its ARR guidance.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
When the CEO of the world’s most valuable company tells you to back up the truck on his own sector, it pays to listen. Jensen Huang did exactly that recently, framing the latest pullback in AI stocks as a gift rather than a warning. The logic mirrors a principle Warren Buffett spent decades drilling into ... Jensen Huang Sounds Eerily Like Warren Buffett as He Tells Investors to Buy the Dip in AI Stocks
Momentus highlighted its strengthened balance sheet and the progress on its current Vigoride space mission.
The SpaceX IPO is twice oversubscribed. Crypto users on Bybit and Kraken can subscribe to tokenized shares using USDC before June 11.
The mean of analysts' price targets for TTM (TTMI) points to a 26.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The mean of analysts' price targets for TSS (TSSI) points to a 29.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The consensus price target hints at a 29.4% upside potential for Charles Schwab (SCHW). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The average of price targets set by Wall Street analysts indicates a potential upside of 85.6% in ABCELLERA BIOLG (ABCL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Bitcoin critic Peter Schiff accused Strategy of omitting the purchase's dilutive effect on common stockholders and declaring "the game is over."
Sandisk stock was back on the rise Monday after two Wall Street firms hiked their forecasts for the memory supplier. Mizuho Securities reiterated an Outperform rating on Sandisk stock and lifted its price target to $2,200 from $1,825 in a research note Sunday. BofA Securities followed suit Monday, maintaining a Buy rating and raising its price target to $2,100 from $1,550.
Wall Street analysts began coverage of recent initial public offering stock Cerebras Systems on Monday with buy ratings.
Buying a home is often seen as a major milestone. For one woman, however, the excitement of becoming a homeowner has been overshadowed by fear. In a recent post on Reddit, she admitted that she and her husband are set...
KEEL is pivoting from crypto to AI/HPC data centers, backed by big liquidity. Yet, forecasts weaken as rivals battle for power.
Corning and Amazon signed a multi-year agreement to provide fiber-optic infrastructure for Amazon's U.S. data center network.
Corning stock rallied on news of a major agreement with Amazon as part of the tech giant's data center expansion.
Sharplink Inc (SBET) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
The heavy selling pressure might have exhausted for Albemarle (ALB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Memory and storage names are leading the tape in early Monday trading, snapping back hard from Friday’s brutal selloff. Micron Technology (NASDAQ:MU) stock is up 8% to $935, while Western Digital (NASDAQ:WDC) and SanDisk (NASDAQ:SNDK) are also rallying sharply. The bounce arrives without a fresh fundamental catalyst, and it looks technical in nature. The trio ... Micron Rockets 8%, Western Digital Surges 7%, SanDisk Pops 6% in Memory-Stock Snap-Back
The average brokerage recommendation (ABR) for Grab (GRAB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Based on the average brokerage recommendation (ABR), Cisco (CSCO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Based on the average brokerage recommendation (ABR), Datadog (DDOG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
According to the average brokerage recommendation (ABR), one should invest in Shopify (SHOP). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
After recent swings, Microsoft stock is down roughly 14% year to date.
You can find stocks with small price points and big potential in today's market.
The massive SpaceX IPO is almost here, with Elon Musk's space exploration and satellite company expected to start trading this Friday.
Cryptocurrency treasury firm Strategy (NASDAQ: $MSTR) has resumed its Bitcoin (CRYPTO: $BTC) purchases following a ...
Investing.com -- Corning (NYSE:GLW) shares jumped 10% Monday after Amazon (NASDAQ:AMZN) announced a multiyear, multibillion-dollar agreement with the company to supply optical fiber, cable, and connectivity solutions for Amazon’s expanding data center infrastructure across the United States.
The S&P 500 is running hot right now.
Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline.
Recently, Zacks.com users have been paying close attention to NIO (NIO). This makes it worthwhile to examine what the stock has in store.